US Patent Issued to GREENWAY DNA on Sept. 30 for "Method and system for providing a personalized cannabinoid treatment regimen" (Oregon, Colorado, Idaho Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,431,227, issued on Sept. 30, was assigned to GREENWAY DNA INC. (Fort Collins, Colo.).

"Method and system for providing a personalized cannabinoid treatment regimen" was invented by Xing-liang Liu (Lake Oswego, Ore.), Douglas Ry Wagner (Pleasant Hill, Ore.), John M. Eustermann (Eagle, Idaho) and Gregg M. Steinberg (Fort Collins, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and systems for providing a personalized cannabinoid treatment regimen to a patient include obtaining genotypes of single nucleotide polymorphisms (SNPs) from a patient's genetic test and modifying base values, such as base dosages or base ratios, using weighting value...